Lineage, Inc. Common Stock (LINE)vsUcommune International Ltd (UK)
LINE
Lineage, Inc. Common Stock
$42.63
-1.32%
REAL ESTATE · Cap: $11.14B
UK
Ucommune International Ltd
$2.78
-11.18%
REAL ESTATE · Cap: $1.58M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 20421% more annual revenue ($5.36B vs $26.12M). LINE leads profitability with a -2.7% profit margin vs -144.9%. LINE earns a higher WallStSmart Score of 34/100 (F).
LINE
Avoid34
out of 100
Grade: F
UK
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+28.9%
Fair Value
$0.68
Current Price
$2.78
$2.10 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -40.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : UK
The strongest argument for UK centers on Price/Book, Debt/Equity.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : UK
The primary concerns for UK are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
LINE is growing revenue faster at 0.4% — sustainability is the question.
UK generates stronger free cash flow (-21M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LINE scores higher overall (34/100 vs 31/100). UK offers better value entry with a 28.9% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.
Visit Website →Ucommune International Ltd
REAL ESTATE · REAL ESTATE SERVICES · China
Ucommune International Ltd provides and manages agile office spaces in China and internationally. The company is headquartered in Beijing, China.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?